Multiple Sclerosis Clinical Trial

LSFG-SKIN, Laser Speckle Flowgraphy

Summary

The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.

View Full Description

Full Description

Laser speckle skin blood flow (LSFG-SKIN) will be recorded in normal subjects and in patients with disorders affecting skin capillary perfusion, which may include cardiovascular disorders, dermatologic disorders, skin wounds, ocular disorders, psychiatric disorders, and neurologic disorders.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Controls

●Healthy normal control subjects ages 18-90

Cardiology Subjects

Ages 18-90
History of dysrhythmia, heart failure, cardiac ischemia, hypertension, peripheral vascular disease

Dermatology Subjects

Ages 18-90
History of inflammatory and cancerous lesions

Endocrine Subjects

Ages 18-90
History of diabetes, thyroid disease

Neurology Subjects

Ages 18-90
History of dementia, headaches, Parkinson's, light sensitivity, stroke, TIA, multiple sclerosis

Psychiatry Subjects

Ages 18-90
History of bipolar, schizophrenia, anxiety, depression

Surgery Subjects

Ages 18-90
History of skin wounds(trauma, chemotherapy, radiation), thermal burns, or plastic and reconstructive surgical procedures.

Ophthalmology Subjects

Ages 18-90
History of ocular disorders caused by hypo perfusion or inflammatory disorders

Exclusion Criteria:

Controls

Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
Angle closure glaucoma

Cardiology Subjects

Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.

Angle closure glaucoma

3. Dermatology Subjects

Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
Angle closure glaucoma

Endocrine Subjects

Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
Angle closure glaucoma

Neurology Subjects

Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
Angle closure glaucoma

Psychiatry Subjects

Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
Angle closure glaucoma

Surgery Subjects

Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
Angle closure glaucoma

Ophthalmology Subjects

Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
Angle closure glaucoma

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

1

Study ID:

NCT03660618

Recruitment Status:

Terminated

Sponsor:

Randy Kardon

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Iowa Department of Ophthalmology
Iowa City Iowa, 52242, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

1

Study ID:

NCT03660618

Recruitment Status:

Terminated

Sponsor:


Randy Kardon

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.